| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/20/1997 | CN1157287A Arylalkyl diazinones |
| 08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
| 08/19/1997 | US5659027 Boronated compounds |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658905 Use of triazine compounds as anxiolytics |
| 08/19/1997 | US5658897 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents |
| 08/19/1997 | US5658896 Water-soluble silicate polymer |
| 08/19/1997 | US5658762 DNA molecules, expression vectors and host cells expressing antigenized antibodies |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997028820A1 Vaccines against varicella zoster virus gene 63 product |
| 08/14/1997 | WO1997028816A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 08/14/1997 | WO1997028797A1 Method of treatment and pharmaceutical composion |
| 08/14/1997 | WO1997028796A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/14/1997 | CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 08/14/1997 | CA2245162A1 Method of treatment and pharmaceutical composition |
| 08/14/1997 | CA2217008A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0788800A1 Method and kit for inducing immunological tolerance |
| 08/13/1997 | EP0788792A1 Matrix type patch preparation |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | EP0788305A1 Composition for inactivating irritants in fluids |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | CN1156993A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/13/1997 | CN1156966A Polynucleotide vaccine for papillomavirus |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/12/1997 | US5656660 Amine or guanidine group-containing tryptase inhibitor |
| 08/12/1997 | US5656659 Substituted dihydrobenzofuran compounds |
| 08/12/1997 | US5656639 Heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme |
| 08/12/1997 | US5656618 Use of an α-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained |
| 08/12/1997 | US5656465 Methods of in vivo gene delivery |
| 08/12/1997 | US5656273 Administering; treats infection caused by helminth, schistosoma, and metazoan |
| 08/12/1997 | US5655652 Center dispense suture package |
| 08/12/1997 | CA1339260C Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 08/07/1997 | WO1997028280A1 Diagnostic method and apparatus |
| 08/07/1997 | WO1997028269A1 Transduced human hematopoietic stem cells |
| 08/07/1997 | WO1997028266A1 Human dnase resistant to actin inhibition |
| 08/07/1997 | WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | WO1997028254A1 Antigenic modulation of cells |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997027872A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | CA2279978A1 Antigenic modulation of cells |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244727A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787184A1 Recombinant alternaria alternata allergens |
| 08/06/1997 | EP0787151A1 Monoclonal antibody fragments having immunosuppressant activity |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787147A1 Compositions and treatment for multiple sclerosis |
| 08/06/1997 | EP0787132A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 08/06/1997 | EP0787127A1 5-lipoxygenase inhibitors |
| 08/06/1997 | EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0787008A1 Method for treating secondary immunodeficiency |
| 08/06/1997 | EP0787003A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 08/06/1997 | EP0786987A1 Enterogenin pharmaceutical form |
| 08/06/1997 | EP0585397B1 Bombesin analogs |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/06/1997 | CN1156449A Dihygropyridine derivatives as bradykinin antagonists |
| 08/06/1997 | CN1156051A Immunological powdered Chiense drug |
| 08/05/1997 | US5654331 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics |
| 08/05/1997 | US5654326 1H-indole-3-glyoxylamide SPLA2 inhibitors |
| 08/05/1997 | US5654323 2-nitrogen-containing functional group-halobenzothiazoles; analgesics; antiinflammatory and hypotensive agents; inhibitors of cytokines (including tumor necrosis factor) and phospholipase; septic shock |
| 08/05/1997 | US5654282 Antiinflammatory agents; viricides; anticancer agents |
| 08/05/1997 | US5653980 For immunoglobulin e mediated allergies |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 07/31/1997 | WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027190A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | WO1997027185A1 Piperidone tachykinin antagonists |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026784A1 Induction of immune response against desired determinants |
| 07/31/1997 | WO1997018790A3 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244189A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2196136A1 2-aryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4] diazepines |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786467A1 Multiple-fucosylated dicarboxylic acids having anti-adhesive properties |
| 07/30/1997 | EP0786457A1 Azole derivative |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0785989A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785945A1 New peptides with immunomodulatory effects |